DURATION-8 randomised controlled trial 1-year results: Efficacy and safety of once-weekly exenatide plus once-daily dapagliflozin versus exenatide or dapagliflozin alone

Authors
Category Primary study
ConferenceDiabetologia
Year 2017
This article has no abstract
Epistemonikos ID: e4458afdd16373cf07376af4d580ab890465142c
First added on: Apr 29, 2026